The National Cancer Institute (NCI) has released three notices of intent to publish Funding Opportunity Announcements (FOAs) that will invite applications for a new initiative, the HIV\/Cervical Cancer Prevention CASCADE Clinical Trials Network.<\/p>\n\n\n\n
The CASCADE network will seek to conduct pragmatic clinical trials evaluating the effectiveness of clinically proven interventions to optimize the cervical cancer screening, management, and pre-cancer treatment cascade for women living with HIV (WLWH). CASCADE network trials will be conducted in intended-use environments in resource-constrained settings in low and middle-income countries and in regions with health disparities in the United States, and will have four major scientific focus areas:<\/p>\n\n\n\n
Further information can be found on the CASCADE page on the NCI website<\/a>.<\/p>\n\n\n\n The three notices of intent provide early visibility of this initiative to encourage development of partnerships to prepare responsive applications for the three components of \u2018CASCADE\u2019:<\/p>\n\n\n\n The FOAs are expected to be published October 15, 2021<\/strong>, with an expected application due date of December 28, 2021<\/strong>. The earliest estimated award\/start date is August 01, 2022<\/strong>.<\/p>\n\n\n\n Details of a planned pre-application webinar will be announced after the publication of the FOAs.<\/p>\n\n\n\n\n